Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Viking Therapeutics is a U.S.-based biopharmaceutical company specializing in the development of innovative, clinical therapeutics. The company is focused on novel drug candidates for metabolic and endocrine diseases, including obesity, NASH, and type 2 diabetes, with the goal of improving patient health and outcomes.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Viking Therapeutics is scheduled to report its next quarterly earnings on 10/28/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Viking Therapeutics last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at -1.10 USD.
Across its last 4 earnings reports, Viking Therapeutics stock moved by ±5.3% on average the following day. The largest reaction was +8% on 10/22/2025; 2 of 4 reactions were positive.
Viking Therapeutics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.